CAD 0.43
(6.25%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.29 CAD | -389.86% |
2022 | -0.06 USD | 84.42% |
2021 | -0.38 CAD | -31.03% |
2020 | -0.29 CAD | 64.63% |
2019 | -0.82 CAD | -1644.26% |
2018 | 0.05 CAD | -55.75% |
2017 | 0.12 CAD | 133.33% |
2016 | -0.36 CAD | -1543.84% |
2015 | -0.02 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.03 USD | 61.87% |
2024 Q2 | -0.05 USD | -50.0% |
2023 Q2 | -0.08 USD | -77.39% |
2023 Q1 | -0.04 USD | 47.1% |
2023 FY | - CAD | -389.86% |
2023 Q4 | -0.09 USD | -1513.21% |
2023 Q3 | -0.01 USD | 93.04% |
2022 Q3 | -0.01 CAD | -111.11% |
2022 Q1 | -0.11 CAD | -16.9% |
2022 Q2 | -0.01 CAD | 94.27% |
2022 FY | - USD | 84.42% |
2022 Q4 | -0.08 USD | -509.77% |
2021 Q1 | -0.10 CAD | -86.22% |
2021 Q2 | -0.07 CAD | 27.5% |
2021 Q3 | -0.09 CAD | -19.31% |
2021 Q4 | -0.09 CAD | -8.79% |
2021 FY | - CAD | -31.03% |
2020 Q1 | -0.12 CAD | -256.08% |
2020 Q3 | 0.02 CAD | 106.87% |
2020 Q4 | -0.05 CAD | -360.68% |
2020 Q2 | -0.30 CAD | -150.0% |
2020 FY | - CAD | 64.63% |
2019 Q1 | -0.04 CAD | 0.0% |
2019 FY | - CAD | -1644.26% |
2019 Q4 | -0.03 CAD | 75.93% |
2019 Q3 | -0.14 CAD | 57.58% |
2019 Q2 | -0.33 CAD | -680.14% |
2018 FY | - CAD | -55.75% |
2017 FY | - CAD | 133.33% |
2016 FY | - CAD | -1543.84% |
2015 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Therma Bright Inc. | -0.02 CAD | -1770.968% |
Theralase Technologies Inc. | -0.02 CAD | -1294.231% |
VentriPoint Diagnostics Ltd. | -0.03 CAD | -832.476% |